[PDF][PDF] COVID-19 and its long-term sequelae: what do we know in 2023

G Lippi, F Sanchis-Gomar, BM Henry - Pol Arch Intern Med, 2023 - researchgate.net
Post‑viral syndrome is a well‑known medical condition characterized by different levels of
physical, cogni‑tive, and emotional impairment that may persist with fluctuating severity after …

Arterial thrombotic events in hospitalized COVID-19 patients: a short review and meta-analysis

M Candeloro, S Schulman - Seminars in Thrombosis and …, 2023 - thieme-connect.com
It is well established that the risk of venous thromboembolism is high in coronavirus disease
19 (COVID-19). The frequency of arterial thromboembolic events (ATEs) in hospitalized …

Deciphering the role of monocyte and monocyte distribution width (MDW) in COVID-19: an updated systematic review and meta-analysis

D Ligi, B Lo Sasso, BM Henry, M Ciaccio… - Clinical Chemistry and …, 2023 - degruyter.com
The SARS-CoV-2 infection is characterized by both systemic and organ hyper-
thromboinflammation, with a clinical course ranging from mild up-to critical systemic …

SARS-CoV-2 breakthrough infections: incidence and risk factors in a large European multicentric cohort of health workers

S Porru, MGL Monaco, G Spiteri, A Carta, MD Pezzani… - Vaccines, 2022 - mdpi.com
Background: The research aimed to investigate the incidence of SARS-CoV-2 breakthrough
infections and their determinants in a large European cohort of more than 60,000 health …

Evolution of SARS-CoV-2 in Spain during the first two years of the pandemic: circulating variants, amino acid conservation, and genetic variability in structural, non …

P Troyano-Hernáez, R Reinosa, Á Holguín - International Journal of …, 2022 - mdpi.com
Monitoring SARS-CoV-2's genetic diversity and emerging mutations in this ongoing
pandemic is crucial to understanding its evolution and ensuring the performance of COVID …

Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune …

IC Hwang, VD Valeriano, JH Song, M Pereira… - Microbial Cell …, 2023 - Springer
Background The use of probiotic lactic acid bacteria as a mucosal vaccine vector is
considered a promising alternative compared to the use of other microorganisms because of …

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD

Q Li, M Zhang, Z Liang, L Zhang, X Wu, C Yang… - MedComm, 2022 - Wiley Online Library
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants, particularly
those with multiple mutations in receptor‐binding domain (RBD), pose a critical challenge to …

Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group

G Lippi, J Favresse, MM Gromiha… - Clinical Chemistry and …, 2022 - degruyter.com
This document, endorsed by the IFCC Working Group on SARS-CoV-2 Variants, aims to
update previous indications for diagnosing acute SARS-CoV-2 infection, taking into …

[HTML][HTML] Is SARS-CoV-2 Omicron (B. 1.1. 529) variant causing different symptoms?

G Lippi, C Mattiuzzi, BM Henry - 2022 - europepmc.org
Background: Since preliminary evidence suggests that the new SARS-CoV-2 Omicron (B.
1.1. 529) variant may cause different symptoms and trigger outbreaks associated with less …

Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study

MT Lee, MS Baek, TW Kim, SY Jung, WY Kim - BMC medicine, 2023 - Springer
Background Previous studies that assessed the risk of cardiovascular outcomes in survivors
of coronavirus disease 2019 (COVID-19) were likely limited by lack of generalizability and …